Grants per year
Personal profile
Research Interests
Crohn's disease and Ulcerative Colitis
Certifications and Licenses
| Gastroenterology | |
| Internal Medicine |
Training Experience
| 1978 | Internship, University of Chicago |
| 1980 | Residency, University of Chicago |
| 1982 | Fellowship, University of Chicago |
Education/Academic qualification
Medicine, MD, University of Illinois at Chicago
… → 1977
Research interests keywords
- Inflammatory Bowel Disease
Fingerprint
Dive into the research topics where stephen B Hanauer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #1425-0003: A Phase IIa, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of BI 706321 Orally Administered for 12 Weeks in Patients with Crohn`s Disease (CD) Receiving Ustekinu
Hanauer, S. B. (PD/PI)
Quintiles, Inc., Boehringer Ingelheim Pharmaceuticals, Inc.
1/17/24 → 1/17/27
Project: Research project
-
Prot #IM047029: A Phase 4, Prospective, Open‐label Study of Ozanimod to Explore the Safety, Efficacy, Quality of Life, and Biomarker Response in Participants with Moderate to Severe Ulcerative Colitis in Clinical Practice
Hanauer, S. B. (PD/PI)
PPD Investigator Services, LLC, Celgene International II Sàrl
9/25/23 → 9/25/26
Project: Research project
-
: Prot #78934804CRD2001: A Phase 2b Randomized, Double‐blind, Active‐ and Placebo‐controlled, Parallel‐ group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy with Guselkumab and Golimumab in Partici
Hanauer, S. B. (PD/PI)
Parexel, Janssen Research & Development, LLC
6/12/23 → 8/24/28
Project: Research project
-
Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial
Bonner, L. B. (PD/PI), Bonner, L. B. (PD/PI), Dulai, P. S. (PD/PI), Dulai, P. S. (PD/PI), Hanauer, S. B. (Co-Investigator), Hanauer, S. B. (Co-Investigator), Hanauer, S. B. (Co-Investigator), Hirano, I. (Co-Investigator), Hirano, I. (Co-Investigator), Scholtens, D. M. (Co-Investigator), Scholtens, D. M. (Co-Investigator), Sumagin, R. (Co-Investigator), Sumagin, R. (Co-Investigator), Sumagin, R. (Co-Investigator), Yang, G.-Y. (Co-Investigator), Yang, G.-Y. (Co-Investigator) & Yang, G.-Y. (Co-Investigator)
National Institute of Diabetes and Digestive and Kidney Diseases
3/15/23 → 2/29/28
Project: Research project
-
Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn’s Disease in the SERENE Studies
Verstockt, B., Pivorunas, V., Mahi, N. A., Smaoui, N., Guay, H., Kennedy, N. A., Goodhand, J. R., Lin, S., Bai, B. Y. H., Hanauer, S. B., Ferrante, M., Panés, J. & Vermeire, S., Apr 1 2024, In: Journal of Crohn's and Colitis. 18, 4, p. 493-505 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease
Vermeire, S., Danese, S., Sandborn, W. J., Schreiber, S., Hanauer, S., Dhaens, G., Nagy, P., Thakur, M., Bliss, C., Cataldi, F., Goetsch, M., Gorelick, K. J. & Reinisch, W., May 1 2024, In: Journal of Crohn's and Colitis. 18, 5, p. 708-719 12 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease
Colombel, J. F., Sands, B. E., Gasink, C., Yeager, B., Adedokun, O. J., Izanec, J., Ma, T., Gao, L. L., Lee, S. D., Targan, S. R., Ghosh, S., Hanauer, S. B. & Sandborn, W. J., Jan 2024, In: Clinical Gastroenterology and Hepatology. 22, 1, p. 144-153.e2Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
EXPLORing the Therapeutic Ceiling in Crohn's Disease: Will Combination Pave the Way?
Torres, J. & Hanauer, S. B., Jul 2024, In: Clinical Gastroenterology and Hepatology. 22, 7, p. 1377-1378 2 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Mesalamine for maintenance therapy in ulcerative colitis: How much, how long?
Sparrow, M. P., Lim, W. C. & Hanauer, S. B., Jun 1 2024, Crohn's Disease: The Complete Guide to Medical Management. CRC Press, p. 115-118 4 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter